Iridium catalyst activates chemotherapy drug directly at targeted cancer cells
Conventional chemotherapy treatments often attack not only cancer cells but also healthy tissue, leading to severe side effects such as hair loss or nausea. The team led by Dr. Thomas Ward from the Department of Chemistry and the Swiss Nanoscience Institute (SNI) at the University of Basel is therefore pursuing an approach that uses artificial metal compounds as catalysts that specifically bind…
We haven't written up this one. Phys.org has the full story — the link below goes straight to it.
